These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4049844)

  • 1. [Immunological and epidemiological effectiveness of the HEVAC B vaccine against hepatitis B in a group at enhanced risk of infection].
    Khukhlovich PA; Viazov SO; Shakhgil'dian IV; Anan'ev VA; Braginskiĭ DM
    Vopr Virusol; 1985; 30(3):330-3. PubMed ID: 4049844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatitis B vaccination with the plasma-derived Hevac-B Pasteur vaccine. A comparison of 2 populations: hospital personnel and hemodialysis patients].
    Di Giandomenico G; Di Giandomenico FW; Volterrani A
    Minerva Med; 1989 Feb; 80(2):149-51. PubMed ID: 2927706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Specific safety and immunogenicity of a subunit vaccine against hepatitis B].
    Viazov SO; Vlasikhina EM; Margolina AN; Favorov MO; Poverennyĭ AM
    Vopr Virusol; 1985; 30(3):324-7. PubMed ID: 4049843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of hepatitis B virus (HBV) vaccine in long term prevention of HBV infection.
    Pongpipat D; Suvatte V; Assatteerawats A
    Asian Pac J Allergy Immunol; 1988 Jun; 6(1):19-22. PubMed ID: 3166643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Active immunoprophylaxis of type B viral hepatitis. Evaluation of the effectiveness of HEVAC-B vaccine in a population at risk].
    Tarocco RP; Faro G; Sargiotto A; Visconti C
    Minerva Med; 1987 Aug; 78(16):1233-41. PubMed ID: 2957614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to hepatitis B vaccine in family members of HBsAg carriers.
    Lok AS; Lai CL; Wu PC; Ng MM
    J Med Virol; 1986 May; 19(1):33-9. PubMed ID: 2939197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
    Frazer IH; Jones B; Dimitrakakis M; Mackay IR
    Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The hepatitis B vaccination campaign carried out from 1982 to 1984 using the Hevac B Pasteur vaccine among 6162 employees of Vaud hospitals].
    Rossier P; Peitrequin R; Frei PC
    Schweiz Med Wochenschr; 1987 Apr; 117(17):629-37. PubMed ID: 3589620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune response to plasma-derived hepatitis B vaccine in hospital health personnel of Parma].
    Magnani G; Bertoletti A; Calzetti C; Campari M; Pizzaferri P; Schianchi C; Vitali P
    Acta Biomed Ateneo Parmense; 1989; 60(1-2):73-9. PubMed ID: 2535096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of hepatitis B immunization with reduced intradermal doses.
    Fadda G; Maida A; Masia C; Obino G; Romano G; Spano E
    Eur J Epidemiol; 1987 Jun; 3(2):176-80. PubMed ID: 2956121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and immunological studies of an experimental series of vaccines against hepatitis B].
    Teokharova MP; Andonov AP; Mineva EG; Draganov PI
    Vopr Virusol; 1984; 29(4):483-7. PubMed ID: 6495708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of immune response to hepatitis B vaccine in Thai blood donors.
    Nuchprayoon C; O-Charoen RO; Vaivanijkul J; Apirakyothin T; Akkawat R; Chumnijarakij T
    Southeast Asian J Trop Med Public Health; 1992 Mar; 23(1):17-21. PubMed ID: 1387972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A plasma subunit vaccine against hepatitis B studied in field trials].
    Ikoev VN; Gorbunov MA; Anan'ev VA; Sumarokov AA; Shavakhabov ShSh; Khalitova KA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Jun; (6):53-8. PubMed ID: 2145718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thymopentin as adjuvant therapy in the hepatitis B vaccination of non- or hyporesponsive subjects].
    Fuliano P; Fontana L; Bigolari M; Bovone U; Orengo G; Astengo F
    Minerva Med; 1990 May; 81(5):407-13. PubMed ID: 2198499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of an anti-hepatitis-B vaccination in a population at risk].
    Stellato M; Carbi S; Tosolini S
    Boll Ist Sieroter Milan; 1989; 68(1):34-41. PubMed ID: 2535244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of isolated anti-HBs antibodies in subjects not vaccinated against hepatitis B viruses].
    Driss F; Zarski JP; Courouce AM; Eme D; Brechot C; Berthelot P; Tron F; Nalpas B
    Gastroenterol Clin Biol; 1991; 15(6-7):477-80. PubMed ID: 1916124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B vaccine: clinical trials in high-risk settings in France. (September 1975-September 1982).
    Goudeau A; Dubois F; Barin F; Dubois MC; Coursaget P
    Dev Biol Stand; 1983; 54():267-84. PubMed ID: 6228468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B vaccine in developing countries: problems and prospects.
    Ayoola EA
    IARC Sci Publ; 1984; (63):297-305. PubMed ID: 6242148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Verification of the safety, inoculability, reactogenicity and antigenic properties of a live recombinant smallpox-hepatitis B vaccine in an experiment in volunteers].
    Chernos VI; Cheliapov NV; Antonova TP; Rakhilina LE; Unanov SS; Al'tshteĭn AD; Zakharova LG; Fodor II; Bendukidze KA; Komarov FI
    Vopr Virusol; 1990; 35(2):132-5. PubMed ID: 2167564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.